2024 Q4 Form 10-Q Financial Statement

#000139390524000350 Filed on October 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $59.64K
YoY Change 16.81%
Operating Profit
YoY Change
Interest Expense $8.852K
YoY Change -65.82%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$66.92K
YoY Change -13.04%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 297.2M shares 297.2M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $20.55K
Short-Term Investments
Other Short-Term Assets $1.845K
YoY Change -56.61%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $22.40K
YoY Change -64.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $311.2K
YoY Change -15.92%
Accrued Expenses $6.705K
YoY Change -84.22%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $931.1K
YoY Change -63.25%
SHAREHOLDERS EQUITY
Retained Earnings -$10.36M
YoY Change 1.29%
Common Stock $297.2K
YoY Change 372.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity $22.40K
YoY Change -64.06%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$66.92K
YoY Change -13.04%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$22.92K
YoY Change -43.21%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -$22.92K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -$22.86K
YoY Change -43.16%
FREE CASH FLOW
Cash From Operating Activities -$22.92K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q3 dei Document Type
DocumentType
10-Q
CY2024Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 dei Document Period End Date
DocumentPeriodEndDate
2024-08-31
CY2024Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q3 dei Entity File Number
EntityFileNumber
000-54500
CY2024Q3 dei Entity Registrant Name
EntityRegistrantName
Cell MedX Corp.
CY2024Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
38-3939625
CY2024Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
1130 Pender Street, West
CY2024Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 820
CY2024Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
CY2024Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
CY2024Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V6E 4A4
CY2024Q3 dei City Area Code
CityAreaCode
844
CY2024Q3 dei Local Phone Number
LocalPhoneNumber
238-2692
CY2024Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q3 dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
297236373 shares
CY2024Q3 us-gaap Cash
Cash
20552 usd
CY2024Q2 us-gaap Cash
Cash
43415 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1845 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2707 usd
CY2024Q3 us-gaap Assets
Assets
22397 usd
CY2024Q2 us-gaap Assets
Assets
46122 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
311167 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
288891 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6705 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28058 usd
CY2024Q3 fil Due To Related Party Current
DueToRelatedPartyCurrent
280848 usd
CY2024Q2 fil Due To Related Party Current
DueToRelatedPartyCurrent
231138 usd
CY2024Q3 fil Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
332407 usd
CY2024Q2 fil Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
324490 usd
CY2024Q3 us-gaap Liabilities
Liabilities
931127 usd
CY2024Q2 us-gaap Liabilities
Liabilities
872577 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7500000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7500000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
297236373 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
297236373 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
297236 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
297236 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8739246 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8736081 usd
CY2024Q3 fil Reserves
Reserves
366493 usd
CY2024Q2 fil Reserves
Reserves
366493 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10362182 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10295263 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
50477 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
68998 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-908730 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-826455 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22397 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46122 usd
CY2024Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
34894 usd
CY2023Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
30001 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
14209 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
5409 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16451 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26156 usd
CY2024Q3 us-gaap Management Fee Expense
ManagementFeeExpense
22500 usd
CY2023Q3 us-gaap Management Fee Expense
ManagementFeeExpense
0 usd
CY2024Q3 fil Research And Development Expense Increase And Decrease
ResearchAndDevelopmentExpenseIncreaseAndDecrease
0 usd
CY2023Q3 fil Research And Development Expense Increase And Decrease
ResearchAndDevelopmentExpenseIncreaseAndDecrease
306 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
59636 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
51054 usd
CY2024Q3 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
1569 usd
CY2023Q3 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
8852 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
25899 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-66919 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-76953 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-18521 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-8932 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-85440 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-85885 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
297236373 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62923063 shares
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2385480 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-76953 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-8932 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2471365 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-826455 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
3165 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-66919 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-18521 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-908730 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-66919 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-76953 usd
CY2024Q3 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
7006 usd
CY2023Q3 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
17070 usd
CY2024Q3 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
1846 usd
CY2023Q3 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
8830 usd
CY2024Q3 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
1569 usd
CY2023Q3 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 usd
CY2024Q3 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
14523 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
5407 usd
CY2024Q3 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-875 usd
CY2023Q3 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-750 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
20702 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1263 usd
CY2024Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-21361 usd
CY2023Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5916 usd
CY2024Q3 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
51026 usd
CY2023Q3 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
10700 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22917 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40357 usd
CY2024Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
54 usd
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
136 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22863 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-40221 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43415 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98295 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20552 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58074 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10362182 usd
CY2024Q3 fil Due To Related Party Current
DueToRelatedPartyCurrent
280848 usd
CY2024Q2 fil Due To Related Party Current
DueToRelatedPartyCurrent
231138 usd
CY2024Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
57394 usd
CY2023Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
30001 usd
CY2024Q3 us-gaap Loans Payable
LoansPayable
288482 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
43925 usd
CY2024Q3 fil Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
332407 usd
CY2024Q2 us-gaap Loans Payable
LoansPayable
287466 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
37024 usd
CY2024Q2 fil Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
324490 usd
CY2024Q3 fil Notes Payable Related Parties Other
NotesPayableRelatedPartiesOther
11119 usd
CY2024Q2 fil Notes Payable Related Parties Other
NotesPayableRelatedPartiesOther
11000 usd
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2500000 shares
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2500000 shares
CY2024Q3 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
0.04
CY2024Q3 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
0.05

Files In Submission

Name View Source Status
0001393905-24-000350-index-headers.html Edgar Link pending
0001393905-24-000350-index.html Edgar Link pending
0001393905-24-000350.txt Edgar Link pending
0001393905-24-000350-xbrl.zip Edgar Link pending
cmxc-20240831.htm Edgar Link pending
cmxc-20240831.xsd Edgar Link pending
cmxc_ex311.htm Edgar Link pending
cmxc_ex312.htm Edgar Link pending
cmxc-20240831_cal.xml Edgar Link unprocessable
cmxc-20240831_lab.xml Edgar Link unprocessable
cmxc-20240831_pre.xml Edgar Link unprocessable
cmxc-20240831_def.xml Edgar Link unprocessable
cmxc-20240831_htm.xml Edgar Link completed
cmxc_ex321.htm Edgar Link pending
cmxc_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable